|
|
 |
|
Viewing report
|
|
|
|
Targeted Drug Delivery Technologies: Players, products & prospects to 2015
Espicom Business Intelligence Ltd, Nov 2007, Pages: 454
Drug Delivery Technology: Assessing its potential
The time when advanced drug delivery was merely a means for profitable product life extension has gone. Drug delivery is now a major component of the pharmaceutical industry’s future and critical to bringing novel therapies to market.
Indeed, without the ability to effectively deliver targeted drugs in therapeutically significant quantities, many of the gene-based agents in research would not be viable. Despite the importance of the sector the pharmaceutical industry has not always been quick to embrace the full range of potential technologies and opportunities.
With so many companies pursuing a wide range of research strategies, it is difficult for industry and commercial executives to get a balanced and independent overview of the competitive landscape.
That is why this major new 4-volume report, Drug Delivery Technology: Players, products and prospects to 2015, is essential reading for everyone in the field, from niche technology specialists through to the investment community and the pharmaceutical industry itself.
By 2015 sales of products using drug delivery technology assessed in this report could exceed US$43 billion.
This report provides a detailed insight into the current and future market for drug delivery technology and...
Provides an overview of the marketplace, outlining current thinking on the technologies being researched and employed.
Appraises currently available products which utilise drug delivery technology and assesses their future.
Examines new product development among major specialist drug delivery companies, critically analysing the prospects at the product level and forecasting sales.
Allows ready comparison on different technologies within a company’s portfolio.
Provides a unique window on the sector’s product launch timetable
Includes detailed appendices which allow at-a-glance reviews of the competitive landscape for both new and up and coming products.
Use this report to...
Assess the strengths and weaknesses of competing products/technologies in the context of specific delivery sectors and development companies;
Identify and review licencing and collaboration partners;
Understand the merits and applications of the main approaches being researched; and, Quantify the commercial prospects for current and future products.
Unique company & technology evaluation
It is vital that management information is reliable, current and insightful. Today, product and company assessment must be seen in a wider competitive and market environment.
In this report we present a précis on each of the leading delivery specialists and potential new delivery platforms and have identified their key attributes, based on a number of criteria including:
Proprietary delivery technology;
Applications of the delivery technology within the pharma industry;
Management/technical expertise of the delivery specialist;
Competition within the delivery technology sector; and,
Products in development/approved utilising the delivery technology.
We have established a competitor ratio analysis based on each of the criteria mentioned above. Each criterion attracts an award of up to 10 points, with a maximum score of 50, thus enabling the establishment of an Espicom “ranking table” in each segment of the market, dependent on their relative attributes.
Multi-point evaluation and scoring assessment
Pharma drugs that utilise drug delivery systems have been evaluated based on a number of parameters, including:
The technology
Comparison of delivery platforms within each area including: activated, degradation or diffusion for controlled release systems; nano-engineered (nanocrystals, nanoparticle, nanosuspension) or nanocarriers (carbon/ceramic, dendrimer, liposome, micelle, polymeric nanoparticles) for nano-enabled delivery; viral or non-viral platforms for nucleic acid delivery and active or passive platforms for targeted delivery systems
The application of the technology within a number of therapy areas
Route of delivery (oral, parenteral, transdermal, implantable), delivery of small molecules/macromolecules and vaccines, additional features such as bioerodible materials etc
The current status of the technology in clinical development or following approval
Number of approved and marketed products, clinical or preclinical development candidates, single or multiple products
Competition within the technology arena
Alternative drug delivery systems to technologies under evaluation, advantages and disadvantages over competitors
The drug delivery specialist’s expertise
Number of drug delivery systems in development, strategic alliances, financial position, marketing presence
The product portfolio
Drug delivery systems under evaluation, products in development, commercialisation/developmental partnerships
Potential drug sales
Based on key events such as market, competition, patent expiry, time of entry into the market
Product samples
Samples for this product is available. Please Login/Register to download these samples.
Customers who bought this item also bought
Drug Delivery Technology - Revolutionizing Cancer Therapies
Nanoparticle Drug Delivery Market Report
Drug Delivery in Cancer - Technologies, Markets and Companies
Drug Delivery Technology - Revolutionizing Cardiovascular Treatment
Who’s Developing What in Drug Delivery?
Drug Delivery Technology - Revolutionizing CNS Therapies
Transdermal Drug Delivery - Technologies, Markets, and Companies
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
Drug Delivery Systems in Cancer Therapeutics
Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
|
|
|
|
